Stoke Therapeutics had a revenue of 10.63M in the quarter ending Sep 30, 2025, with -23.05%. This bring the company's revenue in the last twelve months to 205.63M, Decreased 2.87%. In the fiscal year ending Dec 31, 2024, Stoke Therapeutics had annual revenue of 36.55M with 316.34% growth.